0001127602-24-007883.txt : 20240301
0001127602-24-007883.hdr.sgml : 20240301
20240301162642
ACCESSION NUMBER: 0001127602-24-007883
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240228
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAUNDERS BRENT L
CENTRAL INDEX KEY: 0001268854
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41380
FILM NUMBER: 24710295
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
STREET 2: C/O SCHERING PLOUGH CORP
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch & Lomb Corp
CENTRAL INDEX KEY: 0001860742
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
BUSINESS PHONE: 908-541-5456
MAIL ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-02-28
0001860742
Bausch & Lomb Corp
BLCO
0001268854
SAUNDERS BRENT L
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT
VAUGHAN
A6
L4K 4B4
ONTARIO, CANADA
1
1
CEO and Chair
0
Common Shares, No Par Value
2024-02-28
4
A
0
187919
0
A
562919
D
Non-Qualified Stock Options (right to purchase)
16.85
2024-02-28
4
A
0
569105
0
A
Common Shares, No Par Value
569105
569105
D
Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.
Reflects the grant of stock options to purchase common shares under the Plan.
The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.
The stock options will expire on the tenth anniversary of the grant date.
/s/ Debra E. Levin, attorney-in-fact
2024-03-01